ImmunoCellular Therapeutics, Ltd. filed its S-1 on Jun 24, 2022 for the period ending Dec 31, 2021. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 USD | 0.00% | +40.00% | -9.48% |
1st Jan change | Capi. | |
---|---|---|
-9.48% | 23.79M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+50.24% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- IMUC Stock
- News EOM Pharmaceuticals Holdings, Inc.
- ImmunoCellular Therapeutics, Ltd. Auditor Raises 'Going Concern' Doubt